Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy

Starting soon · Phase 2

Conditions studied: Hypoxic-Ischemic Encephalopathy

In brief

The main objective of this study is to assess pharmacokinetics features of IV sildenafil in neonates with hypoxic-ischemic encephalopathy and treated by controlled hypothermia. This phase 2 study will prepare a large phase 3 randomized controlled trial to demonstrate the superiority of a combinatory therapy associating IV sildenafil and controlled hypothermia compared to Placebo and controlled hypothermia, on survival without brain lesions on MRI at discharge, in neonates born after 36 weeks of gestation.

Key facts

Study ID
NCT06810284
Run by
Assistance Publique - Hôpitaux de Paris
People needed
24
Starts
2026-10-01
Expected to finish
2029-05-01
Last updated by the study team
2026-03-31

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.